FDA — authorised 11 February 2021
- Marketing authorisation holder: REGENERON PHARMACEUTICALS
- Status: approved
🇺🇸 Evkeeza in United States
FDA authorised Evkeeza on 11 February 2021
Marketing authorisations
FDA — authorised 11 February 2021
- Application: BLA761181
- Marketing authorisation holder: REGENERON PHARMACEUTICALS
- Local brand name: EVKEEZA
- Indication: SOLUTION — INJECTION
- Status: approved
Evkeeza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Evkeeza approved in United States?
Yes. FDA authorised it on 11 February 2021; FDA authorised it on 11 February 2021.
Who is the marketing authorisation holder for Evkeeza in United States?
REGENERON PHARMACEUTICALS holds the US marketing authorisation.